The Effect of Tranexamic Acid on the Blood Loss Volumes in the Patients Underwent Orthognathic Surgeries

Document Type: Short Communication


1 Professor, Department of Oral and Maxillofacial Surgery, School of Dentistry, Islamic Azad University, Tehran Branch, Tehran, Iran

2 Assistant Professor, Department of Oral and Maxillofacial Surgery, School of Dentistry, Qazvin University of Medical Sciences, Qazvin, Iran

3 Student of Dentistry, School of Dentistry, Qazvin University of Medical Sciences, Qazvin, Iran


Background and Aims: Tranexamic acid has been used to decrease blood loss volumes and the subsequent need for blood transfusion in the orthopedic, spinal and cardiac surgeries.
Methods: In this prospective controlled randomized clinical trial study, 24 candidates for orthognathic surgeries received tranexamic acid (20 mg/kg) intravenously just before the surgery while matched control patients received normal saline. The patients underwent the surgeries according to the standard protocol. Patients’ blood hemoglobin and hematocrit levels were calculated before and after the surgeries and blood loss volumes were calculated using these criteria.
Results: The blood loss was estimated as 693.65 ± 81.24 and 1024.00 ± 75.41 ml regarding blood hemoglobin values before and after the surgery in intervention and control groups, respectively; while it was estimated as 660.93 ± 62.78 and 1052.00 ± 48.54 ml concerning patients’ blood hematocrit levels before and after the surgery in those groups, respectively. Significant differences were noted between the intervention and control patients regarding blood loss volumes determined via the two methods (both: P < 0.001). 
Conclusion: As suggested by the results, the intravenous injection of tranexamic acid (20 mg/kg) just before the orthognathic surgeries was associated with the significant decreased blood loss volumes compared to the control patients.


  1. Khechoyan DY. Orthognathic surgery: general considerations. Semin Plast Surg 2013; 27(3): 133-6.
  2. Scariot R, da Costa DJ, Rebellato NLB, Müller PR, da Conceição Ferreira R. Epidemiological analysis of orthognathic surgery in a hospital in Curitiba, Brazil: Review of 195 cases. Revista Española de Cirugía Oral y Maxilofacial 2010; 32(4): 147-54.
  3. Kelley TC, Tucker KK, Adams MJ, Dalury DF. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion 2014; 54(1): 26-30.
  4. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184.
  5. Dhillon MS, Bali K, Prabhakar S. Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage. Indian J Orthop 2011; 45(2): 148-52.
  6. Neilipovitz DT. Tranexamic acid for major spinal surgery. Eur Spine J 2004; 13(Suppl 1): S62-S65.
  7. Mengistu AM, Rohm KD, Boldt J, Mayer J, Suttner SW, Piper SN. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. Anesth Analg 2008; 107(2): 391-7.
  8. Patatanian E, Fugate SE. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction. Ann Pharmacother 2006; 40(12): 2205-10.
  9. Carter G, Goss A, Lloyd J, Tocchetti R. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. J Oral Maxillofac Surg 2003; 61(12): 1432-5.
  10. Carter G, Goss A. Tranexamic acid mouthwash--a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 2003; 32(5): 504-7.
  11. Andrews JJ, Miller RD, Afton-Bird G. Miller's Anesthesia. 6th ed. London, UK: Elsevier/Churchill Livingstone; 2005. p. 902.
  12. Johansson T, Engquist M, Pettersson LG, Lisander B. Blood loss after total hip replacement: a prospective randomized study between wound compression and drainage. J Arthroplasty 2005; 20(8): 967-71.
  13. Hurle R, Poma R, Maffezzini M, Manzetti A, Piccinelli A, Taverna G, et al. A simple mathematical approach to calculate blood loss in radical prostatectomy. Urol Int 2004; 72(2): 135-9.
  14. Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 2006; 13(2): 106-10.
  15. Hamid RS, Fathi WK, Al Wattar WT. The effect of tranexamic acid (Cyclokapron) on post–surgical bleeding following the removal of impacted lower wisdom teeth in healthy individuals. Al-Rafidain Dent J 2008; 8(2): 225-30.
  16. Zellin G, Rasmusson L, Palsson J, Kahnberg KE. Evaluation of hemorrhage depressors on blood loss during orthognathic surgery: a retrospective study. J Oral Maxillofac Surg 2004; 62(6): 662-6.
  17. Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005; 102(4): 727-32.
  18. Ker K. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
  19. Badeaux J, Hawley D. Effectiveness of intravenous Tranexamic Acid (TXA) administration in managing perioperative blood loss in patients undergoing spine surgery: a systematic review protocol. JBI Database of Systematic Reviews & Implementation Report 2013; 11(5): 123-31.
  20. Fu DJ, Chen C, Guo L, Yang L. Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. Chin J Traumatol 2013; 16(2): 67-76.
  21. Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007; 7(1): 185-94.